These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19245436)

  • 21. Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026.
    Moncunill G; Armand-Ugón M; Clotet-Codina I; Pauls E; Ballana E; Llano A; Romagnoli B; Vrijbloed JW; Gombert FO; Clotet B; De Marco S; Esté JA
    Mol Pharmacol; 2008 Apr; 73(4):1264-73. PubMed ID: 18182480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.
    Princen K; Hatse S; Vermeire K; Aquaro S; De Clercq E; Gerlach LO; Rosenkilde M; Schwartz TW; Skerlj R; Bridger G; Schols D
    J Virol; 2004 Dec; 78(23):12996-3006. PubMed ID: 15542651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXC-chemokine receptor 4 is not a coreceptor for human herpesvirus 7 entry into CD4(+) T cells.
    Zhang Y; Hatse S; De Clercq E; Schols D
    J Virol; 2000 Feb; 74(4):2011-6. PubMed ID: 10644374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias.
    Zeng Z; Samudio IJ; Munsell M; An J; Huang Z; Estey E; Andreeff M; Konopleva M
    Mol Cancer Ther; 2006 Dec; 5(12):3113-21. PubMed ID: 17172414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Lentiviral CXCR4 overexpression and knockdown model in colorectal cancer cell lines reveals plerixafor-dependent suppression of SDF-1α-induced migration and invasion.
    Heckmann D; Laufs S; Maier P; Zucknick M; Giordano FA; Veldwijk MR; Eckstein V; Wenz F; Zeller WJ; Fruehauf S; Allgayer H
    Onkologie; 2011; 34(10):502-8. PubMed ID: 21985848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1alpha: implications for development of selective CXCR4 antagonists.
    Gupta SK; Pillarisetti K; Thomas RA; Aiyar N
    Immunol Lett; 2001 Aug; 78(1):29-34. PubMed ID: 11470148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus.
    Aiuti A; Turchetto L; Cota M; Cipponi A; Brambilla A; Arcelloni C; Paroni R; Vicenzi E; Bordignon C; Poli G
    Blood; 1999 Jul; 94(1):62-73. PubMed ID: 10381499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity.
    Hesselgesser J; Liang M; Hoxie J; Greenberg M; Brass LF; Orsini MJ; Taub D; Horuk R
    J Immunol; 1998 Jan; 160(2):877-83. PubMed ID: 9551924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4-Chemokine receptor hybrids in human immunodeficiency virus type 1 infection.
    Klasse PJ; Rosenkilde MM; Signoret N; Pelchen-Matthews A; Schwartz TW; Marsh M
    J Virol; 1999 Sep; 73(9):7453-66. PubMed ID: 10438835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of SDF-1/CXCR4-induced Ca2+ signaling by fluorometric imaging plate reader (FLIPR) and flow cytometry.
    Princen K; Hatse S; Vermeire K; De Clercq E; Schols D
    Cytometry A; 2003 Jan; 51(1):35-45. PubMed ID: 12500303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemically synthesized SDF-1alpha analogue, N33A, is a potent chemotactic agent for CXCR4/Fusin/LESTR-expressing human leukocytes.
    Ueda H; Siani MA; Gong W; Thompson DA; Brown GG; Wang JM
    J Biol Chem; 1997 Oct; 272(40):24966-70. PubMed ID: 9312101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.
    Trkola A; Paxton WA; Monard SP; Hoxie JA; Siani MA; Thompson DA; Wu L; Mackay CR; Horuk R; Moore JP
    J Virol; 1998 Jan; 72(1):396-404. PubMed ID: 9420238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
    Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
    Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1.
    Gotoh K; Yoshimori M; Kanbara K; Tamamura H; Kanamoto T; Mochizuki K; Fujii N; Nakashima H
    J Infect Chemother; 2001 Mar; 7(1):28-36. PubMed ID: 11406754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45.
    Fernandis AZ; Cherla RP; Ganju RK
    J Biol Chem; 2003 Mar; 278(11):9536-43. PubMed ID: 12519755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desensitization of CXC chemokine receptor 4, mediated by IL-16/CD4, is independent of p56lck enzymatic activity.
    Van Drenth C; Jenkins A; Ledwich L; Ryan TC; Mashikian MV; Brazer W; Center DM; Cruikshank WW
    J Immunol; 2000 Dec; 165(11):6356-63. PubMed ID: 11086073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains.
    Tian S; Choi WT; Liu D; Pesavento J; Wang Y; An J; Sodroski JG; Huang Z
    J Virol; 2005 Oct; 79(20):12667-73. PubMed ID: 16188969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV co-receptors as targets for antiviral therapy.
    Schols D
    Curr Top Med Chem; 2004; 4(9):883-93. PubMed ID: 15134547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCR4 function requires membrane cholesterol: implications for HIV infection.
    Nguyen DH; Taub D
    J Immunol; 2002 Apr; 168(8):4121-6. PubMed ID: 11937572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TCR activation inhibits chemotaxis toward stromal cell-derived factor-1: evidence for reciprocal regulation between CXCR4 and the TCR.
    Peacock JW; Jirik FR
    J Immunol; 1999 Jan; 162(1):215-23. PubMed ID: 9886389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.